Back
Marriott Vacations Worldwide Vs. Keros Therapeutics Industry Stock Comparison
Sell
37
VAC
Marriott Vacations Worldwide
Last Price:
76.50
Seasonality Move:
3.84%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Sell
37
Marriott Vacations Worldwide (VAC)
is a Sell
Is Marriott Vacations Worldwide a Buy, Sell or Hold?
- The current Marriott Vacations Worldwide [VAC] share price is $75.76. The Score for VAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- VAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VAC Stock Price Chart
What is Marriott Vacations Worldwide's stock price today?
-
The Marriott Vacations Worldwide share price today is $75.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
VAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 55.17 | Buy |
| Chaikin Money Flow: | 211690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.31 - 74.69) | Buy |
| Bollinger Bands (100): | (73.38 - 91.98) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 64.2 | Buy |
| Chaikin Money Flow: | -162874 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.46 - 56.8) | Buy |
| Bollinger Bands (100): | (45.02 - 53.82) | Buy |
VAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.5 | Buy |
| 20-day SMA: | 72.98 | Buy |
| 50-day SMA: | 75.38 | Buy |
| 200-day SMA: | 87.4 | Sell |
| 8-day EMA: | 74.41 | Buy |
| 20-day EMA: | 73.67 | Buy |
| 50-day EMA: | 75.97 | Sell |
| 200-day EMA: | 87.42 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.92 | Buy |
| 20-day SMA: | 53.86 | Buy |
| 50-day SMA: | 50.03 | Buy |
| 200-day SMA: | 52.7 | Buy |
| 8-day EMA: | 55.87 | Buy |
| 20-day EMA: | 53.93 | Buy |
| 50-day EMA: | 51.33 | Buy |
| 200-day EMA: | 49.85 | Buy |
Marriott Vacations Worldwide Earnings Growth & VAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.51 per share, a decrease next quarter of $0.07 per share, a decrease this year of $1.53 per share, and an increase next year of $1.12 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Marriott Vacations Worldwide Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||